Paget's disease: Recent articles in JBMR


Seitz S. Paget's disease of bone: histologic analysis of 754 patients. J Bone Miner Res 2009;24(1):62-9.

Rea SL. Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin binding. J Bone Miner Res 2009;24(7):1216-23.

Najat D. Characterization of a non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in Paget's disease of bone. J Bone Miner Res 2009;24(4):632-42.

Merchant A. Somatic mutations in SQSTM1 detected in affected tissues from patients with sporadic Paget's disease of bone. J Bone Miner Res 2009;24(3):484-94.

Langston AL. Randomised Trial of Intensive Bisphosphonate Treatment Versus Symptomatic Management in Paget's Disease of Bone. J Bone Miner Res 2009.

Kanzaki S. Bisphosphonate therapy ameliorates hearing loss in mice lacking osteoprotegerin. J Bone Miner Res 2009;24(1):43-9.

Wermers RA. Morbidity and mortality associated with Paget's disease of bone: a population-based study. J Bone Miner Res 2008;23(6):819-25.

Nagy ZB. Gene expression profiling in Paget's disease of bone: upregulation of interferon signaling pathways in pagetic monocytes and lymphocytes. J Bone Miner Res 2008;23(2):253-9.

Lucas GJ. Identification of a major locus for Paget's disease on chromosome 10p13 in families of British descent. J Bone Miner Res 2008;23(1):58-63.

Whyte MP. Juvenile Paget's disease: the second reported, oldest patient is homozygous for the TNFRSF11B "Balkan" mutation (966_969delTGACinsCTT), which elevates circulating immunoreactive osteoprotegerin levels. J Bone Miner Res 2007;22(6):938-46.

Ralston SH. Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of bone. J Bone Miner Res 2007;22(4):569-77.

Naot D. Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone. J Bone Miner Res 2007;22(2):298-309.

Merlotti D. Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. J Bone Miner Res 2007;22(10):1510-7.

Hosking D. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate. J Bone Miner Res 2007;22(1):142-8.

Collet C. Paget's disease of bone in the French population: novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlations. J Bone Miner Res 2007;22(2):310-7.

Bolland MJ. Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations. J Bone Miner Res 2007;22(3):411-5.

Beyens G. Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget's disease of bone. J Bone Miner Res 2007;22(7):1062-71.

Sundaram M. Imaging of Paget's disease and fibrous dysplasia of bone. J Bone Miner Res 2006;21 Suppl 2:P28-30.

Siris ES. Medical management of Paget's disease of bone: indications for treatment and review of current therapies. J Bone Miner Res 2006;21 Suppl 2:P94-8.

Singer FR. Ultrastructure of bone cells in Paget's disease of bone. J Bone Miner Res 2006;21 Suppl 2:P51-4.

Shankar S. Biochemical assessment of Paget's disease of bone. J Bone Miner Res 2006;21 Suppl 2:P22-7.

Selby PL. Canine distemper virus induces human osteoclastogenesis through NF-kappaB and sequestosome 1/P62 activation. J Bone Miner Res 2006;21(11):1750-6.

Selby PL. Guidelines for the diagnosis and management of Paget's disease: a UK perspective. J Bone Miner Res 2006;21 Suppl 2:P92-3.

Rendina D. Evidence for increased clinical severity of familial and sporadic Paget's disease of bone in Campania, southern Italy. J Bone Miner Res 2006;21(12):1828-35.

Rea SL. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype. J Bone Miner Res 2006;21(7):1136-45.

Poor G. Epidemiology of Paget's disease in Europe: the prevalence is decreasing. J Bone Miner Res 2006;21(10):1545-9.

Parvizi J. Surgical management of Paget's disease of bone. J Bone Miner Res 2006;21 Suppl 2:P75-82.

Papapoulos SE. Acquired resistance to bisphosphonates in Paget's disease of bone. J Bone Miner Res 2006;21 Suppl 2:P88-91.

Morissette J. Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget's disease of bone. J Bone Miner Res 2006;21 Suppl 2:P38-44.

Middleton-Hardie C. Deletion of aspartate 182 in OPG causes juvenile Paget's disease by impairing both protein secretion and binding to RANKL. J Bone Miner Res 2006;21(3):438-45.

Lucas GJ. Contribution of genetic factors to the pathogenesis of Paget's disease of bone and related disorders. J Bone Miner Res 2006;21 Suppl 2:P31-7.

Leach RJ. Clinical and cellular phenotypes associated with sequestosome 1 (SQSTM1) mutations. J Bone Miner Res 2006;21 Suppl 2:P45-50.

Kurihara N. Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice. J Bone Miner Res 2006;21(3):446-55.

Kurihara N. Experimental models of Paget's disease. J Bone Miner Res 2006;21 Suppl 2:P55-7.

Hansen MF. Osteosarcoma in Paget's disease of bone. J Bone Miner Res 2006;21 Suppl 2:P58-63.

Gennari L. Paget's disease of bone in Italy. J Bone Miner Res 2006;21 Suppl 2:P14-21.

Cundy T. Is the prevalence of Paget's disease of bone decreasing? J Bone Miner Res 2006;21 Suppl 2:P9-13.

Cooper C. Update on the epidemiology of Paget's disease of bone. J Bone Miner Res 2006;21 Suppl 2:P3-8.

Brandi ML. What is the relationship between Paget's disease of bone and hyperparathyroidism? J Bone Miner Res 2006;21 Suppl 2:P69-74.

Bone HG. Nonmalignant complications of Paget's disease. J Bone Miner Res 2006;21 Suppl 2:P64-8.